0
Cara Therapeutics Inc
- 11-50 Employees
- Based in Stamford, Connecticut
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Its lead product candidate includes intravenous CR845, which has completed Phase 2 clinical trials for the treatment acute postoperative pain in adult patients, as well as in Phase 2 clinical…More
Social Media Links
Cara Therapeutics Inc
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Cara Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
